Meprobamate and aspirin and Gait abnormal - a phase IV clinical study of FDA data
We study 1,141 people who take Meprobamate and aspirin or have Gait abnormal. No report of Gait abnormal is found in people who take Meprobamate and aspirin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
No report is found.
What is Meprobamate And Aspirin?
Meprobamate and aspirin has active ingredients of aspirin; meprobamate.
What is Gait Abnormal?
Gait abnormal is found to be associated with 732 drugs and 449 conditions by eHealthMe.
Do you take Meprobamate and aspirin and have Gait abnormal?Check whether Gait abnormal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Meprobamate and aspirin:
Gait abnormal treatments and more:
- Gait abnormal (1,141 reports)
COVID vaccines that are related to Gait abnormal:
- Gait abnormal in Moderna COVID Vaccine
- Gait abnormal in Pfizer BioNTech Covid Vaccine
- Gait abnormal in Johnson and Johnson Covid Vaccine
How severe was Gait abnormal and when was it recovered:
Expand to all the drugs that have ingredients of aspirin; meprobamate:
All the drugs that are associated with Gait abnormal:
All the conditions that are associated with Gait abnormal:
How the study uses the data?
The study uses data from the FDA. It is based on aspirin; meprobamate (the active ingredients of Meprobamate and aspirin) and Meprobamate and aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.